Advertisement
Screener

CHECK POINT SOFTWARE TECHNOLOGIES LTD. (CHKP) Spending and interest coverage

CHECK POINT SOFTWARE TECHNOLOGIES LTD. (CHKP) Spending and interest coverage

  • R&D / revenue · 12 months: Value 16.76%; Formula and calculation Research and development expense / revenue. Period ending 2025-12-31..
  • Stock-based compensation / revenue · 12 months: Value 7.54%; Formula and calculation Share-based compensation / revenue. Period ending 2025-12-31..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months16.76%Research and development expense / revenue. Period ending 2025-12-31.

$456.70M ÷ $2.73B × 100 ≈ 16.76%

Stock-based compensation / revenue · 12 months7.54%Share-based compensation / revenue. Period ending 2025-12-31.

$205.60M ÷ $2.73B × 100 ≈ 7.54%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending456.70M USDResearch and Development Expense
Revenue2.73B USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation205.60M USDShare-based Payment Arrangement, Noncash Expense
Operating income831.10M USDOperating Income (Loss)
Interest expense · reported / estimated(m) · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2025-12-31$456.70M$2.73B$205.60M$831.10M(m)16.76%7.54%(m)(m)
2025-09-30$433.50M$2.68B$179.00M$852.50M(m)16.15%6.67%(m)(m)
2024-12-31$394.90M$2.56B$149.70M$876.00M(m)15.40%5.84%(m)(m)
2024-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-12-31$368.90M$2.41B$145.30M$899.10M(m)15.28%6.02%(m)(m)
2022-12-31$349.90M$2.33B$131.40M$884.30M(m)15.02%5.64%(m)(m)
2021-12-31$292.70M$2.17B$120.30M$907.50M(m)13.51%5.55%(m)(m)
2020-12-31$252.80M$2.06B$112.50M$904.20M(m)12.24%5.45%(m)(m)
2019-12-31$239.20M$1.99B$106.70M$881.80M(m)11.99%5.35%(m)(m)
2018-12-31$211.52M$1.92B$89.33M$913.77M(m)11.04%4.66%(m)(m)
2017-12-31$192.39M$1.85B$87.46M$923.92M(m)10.37%4.72%(m)(m)
2016-12-31$178.37M$1.74B$82.73M$852.27M(m)10.24%4.75%(m)(m)
2015-12-31$149.28M$1.63B$76.30M$839.72M(m)9.16%4.68%(m)(m)
2014-12-31$133.30M$1.50B$63.17M$801.05M(m)8.91%4.22%(m)(m)
2013-12-31$121.76M$1.39B$51.11M$760.90M(m)8.73%3.67%(m)(m)
2012-12-31$111.91M$1.34B$45.29M$746.53M(m)8.33%3.37%(m)(m)
2011-12-31$110.15M$1.25B$39.84M$642.17M(m)8.83%3.19%(m)(m)
2010-12-31$105.75M$1.10B$35.18M$535.01M(m)9.63%3.20%(m)(m)
2009-12-31$89.74M$924.42M$30.91M$415.02M(m)9.71%3.34%(m)(m)
2008-12-31$91.63M$808.49M$32.33M$356.50M(m)11.33%4.00%(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.